pharma news today obesity drugs glp-1 october 2025 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 2024 was a record year

Breakthrough in Diabetes & Obesity Treatment!Discover the science behind Dual GIP and GLP-1 Receptor Agonistsa revolutionary class of medications changin...

She was prediabetic, a condition in which blood sugar levels are higher than normal, and her doctor prescribed Ozempic to help her avoid developing diabetes

Nu-U.Ai | Post GLP-1 forum & AI chatbot SaaS company profile on GetLatka revenue, ARR, valuation, funding rounds, customers, team size, and growth.

PHARMACIST FORMULATED FOR GLP-1 USERS Developed by an expert pharmacist, GLPLUS+ is specifically designed for GLP-1 users seeking relief from digestive discomfort, nausea, and bloating

GLP-1 receptor agonists (GLP-1RAs): cardiovascular actions and therapeutic potential